Breast cancer
OncoAlert Horizons
Two experts on one evolving question in breast cancer, newest first.
Adjuvant treatment challenges in early HR+/HER2− breast cancer: the emerging role of next-generation oral SERDs
Dr. Sibylle Loibl and Dr. Rupert Bartsch
June 15, 2026. 14 minutes.
The new sequencing challenge in HER2+ metastatic breast cancer
Dr. Javier Cortés and Dr. Elisa Agostinetto
June 10, 2026. 17 minutes.
Early HER2+ breast cancer: escalate, de-escalate or personalize?
Dr. Giampaolo Bianchini and Dr. François-Clément Bidard
May 26, 2026. 20 minutes.
What comes after CDK4/6 inhibitors? SERDs, combinations and the future of HR+ advanced breast cancer
Dr. Sherene Loi and Dr. Elisa Agostinetto
May 20, 2026. 14 minutes.
On The Go
Short upright videos. Tap one to watch, then swipe for the next.
NATALEE 6-Year Update: Overall Survival Benefit With Ribociclib | ESMO 2026
Dr. Gil Morgan
TOP-1 Trial: Can We Omit Both Radiotherapy and Endocrine Therapy?
Dr. Elisabetta Bonzano
Podium2Screen
Podium2Screen videos on breast cancer, newest first.
evERA : Giredestrant + Everolimus: evERA Biomarker Analyses | Sara Tolaney | ESMO 2026
Dr. Sara Tolaney
October 28, 2026.
Highlights
Paper picks and regulatory news on breast cancer, newest first.
Videos
Round-ups and expert picks on breast cancer, newest first.
Oncology Here & Now
The podcast: short conversations, one tumor type at a time.
Adjuvant CDK4/6 inhibitors in breast cancerDr. Maryam Lustberg and Dr. Elisa AgostinettoSeason 1, Episode 2, March 14, 2025
From the Colloquium
The breast cancer day of the sixth OncoAlert Colloquium, February 2026: 10 talks.
Early and metastatic disease, diagnostics, surgery, radiotherapy and global equity.
Moderated by Dr. Elisa Agostinetto and Dr. Gil Morgan.
ER+ metastatic breast cancerDr. Erika Hamilton
HER2+ metastatic breast cancerDr. Stephanie Graff
Advanced triple-negative breast cancerDr. Hope Rugo
Early triple-negative breast cancerDr. Rebecca Dent
ER+ early breast cancerDr. Matteo Lambertini
HER2+ early breast cancerDr. Evandro de Azambuja
Breast cancer pathologyDr. Roberto Salgado
Surgical breast oncologyDr. Isabel Rubio
Breast cancer radiotherapyDr. Icro Meattini
How I treat when options are limitedDr. Lazar Popovic
Faculty
The OncoAlert faculty for breast cancer, in a new order on every visit.
Dr. Jame Abraham
Cleveland Clinic
Breast Cancer
Dr. Elisa Agostinetto
Institut Jules Bordet, Brussels
Breast cancer
Dr. Fabrice André
Gustave Roussy / Paris Saclay
Breast cancer
Dr. Evandro de Azambuja
Institut Jules Bordet, Brussels
Breast cancer
Dr. Javier Cortes
International Breast Cancer Center
Breast Cancer
Dr. Rebecca Dent
National Cancer Centre Singapore
Breast Cancer
Dr. Stephanie Graff
Sarah Cannon / Menorah Medical
Breast cancer
Dr. Julie R. Gralow
ASCO
Breast cancer
Dr. Erika Hamilton
Sarah Cannon Research Institute
Breast cancer
Dr. Nadia Harbeck
LMU University Hospital Munich
Breast cancer
Dr. Matteo Lambertini
IRCCS San Martino / U Genova
Breast cancer
Dr. Sherene Loi
Peter Mac, Melbourne
Breast cancer
Dr. Icro Meattini
University of Florence
Breast cancer
Dr. Aleix Prat
Hospital Clínic Barcelona
Breast cancer
Dr. Isabel Teresa Rubio
ESSO past president
Breast Cancer
Dr. Hope Rugo
UCSF Helen Diller
Breast cancer
Dr. Sara Tolaney
Dana-Farber / Harvard
Breast cancer
Past congresses
Each opens that congress’s highlights, showing only breast cancer.
ESMO 2025
Berlin
5 pieces